Department of Orthopedics and Traumatology, Mersin University Medical School, Zeytinlibahce cd, Mersin, Turkey.
J Bone Joint Surg Am. 2013 Jan 16;95(2):117-25. doi: 10.2106/JBJS.K.01135.
Implant-related infections with bacteria resistant to multiple antibiotics represent one of the major problems in orthopaedic surgery. It was our hypothesis that local application of bacteriophages, which are bacteria-destroying viruses, would be effective against biofilm-forming bacteria.
An implant-related infection model was created using methicillin-resistant Staphylococcus aureus (MRSA) in forty-eight rats and Pseudomonas aeruginosa in another forty-eight rats. Each group was divided into four subgroups; one subgroup received a bacterium-specific bacteriophage (Sb-1 in the MRSA group and PAT14 in the Pseudomonas aeruginosa group), one received antibiotic for fourteen days (20 mg/kg/day teicoplanin in the MRSA group, and 120 mg/kg/day imipenem + cilastatin and 25 mg/kg/day amikacin in the Pseudomonas group), one received antibiotic and bacteriophage, and one received no treatment. Animals receiving bacteriophage therapy were injected locally with 107 bacteriophages in a 0.1-mL suspension on three consecutive days. All animals were killed on the fifteenth day after initiation of treatment, and the tibia was excised. Results were assessed with use of microbiology, light microscopy, and electron microscopy.
In the MRSA group, the antibiotic administration significantly decreased the number of colony-forming units per subject in quantitative cultures (control subgroup, 50,586; bacteriophage, 30,788; antibiotic, 17,165; antibiotic + bacteriophage, 5000; p = 0.004 for the comparison of the latter group with the control). Biofilm was absent only in the antibiotic + bacteriophage subgroup. In the Pseudomonas group, the number of colony-forming units per subject in quantitative cultures was significantly lower in each treatment subgroup compared with the control subgroup (control subgroup, 14,749; bacteriophage, 6484 [p = 0.016]; antibiotic, 2619 [p = 0.01]; antibiotic + bacteriophage, 1705 [p < 0.001]). The value in the antibiotic + bacteriophage subgroup was also significantly lower than the values in the other subgroups (p = 0.006). Biofilm thickness did not differ significantly among the subgroups in the Pseudomonas group.
The addition of bacteriophage treatment to an appropriate antibiotic regimen helped to dissolve the biofilm of both types of bacteria studied. This effect on MRSA was more pronounced than that on Pseudomonas aeruginosa.
耐多种抗生素的细菌导致的植入物相关感染是骨科手术中的主要问题之一。我们假设局部应用噬菌体(一种能破坏细菌的病毒)将对生物膜形成细菌有效。
我们使用耐甲氧西林金黄色葡萄球菌(MRSA)在 48 只大鼠中、铜绿假单胞菌在另外 48 只大鼠中创建了植入物相关感染模型。每组分为四个亚组;一组接受细菌特异性噬菌体(MRSA 组中的 Sb-1 和铜绿假单胞菌组中的 PAT14),一组接受 14 天的抗生素治疗(MRSA 组中每天 20mg/kg 替考拉宁,铜绿假单胞菌组中每天 120mg/kg 亚胺培南+西司他丁和 25mg/kg 阿米卡星),一组接受抗生素和噬菌体治疗,一组不接受任何治疗。接受噬菌体治疗的动物在连续 3 天内用 0.1ml 悬浮液局部注射 107 个噬菌体。所有动物均在治疗开始后第 15 天处死,取出胫骨。通过微生物学、光镜和电子显微镜评估结果。
在 MRSA 组中,抗生素治疗可显著降低定量培养中每个受试者的菌落形成单位数(对照组亚组为 50586;噬菌体亚组为 30788;抗生素亚组为 17165;抗生素+噬菌体亚组为 5000;与对照组相比,后一组的 p 值=0.004)。仅在抗生素+噬菌体亚组中不存在生物膜。在铜绿假单胞菌组中,每个治疗亚组的受试者定量培养中的菌落形成单位数均显著低于对照组(对照组亚组为 14749;噬菌体亚组为 6484[p=0.016];抗生素亚组为 2619[p=0.01];抗生素+噬菌体亚组为 1705[p<0.001])。抗生素+噬菌体亚组的值也明显低于其他亚组(p=0.006)。在铜绿假单胞菌组中,各亚组的生物膜厚度无显著差异。
将噬菌体治疗与适当的抗生素方案联合应用有助于溶解所研究的两种细菌的生物膜。这种对 MRSA 的作用比铜绿假单胞菌更明显。